Evogene Ltd.
A computational biology company using AI to develop life-science products.
EVGN | TA
Overview
Corporate Details
- ISIN(s):
- IL0011050551
- LEI:
- Country:
- Israel
- Address:
- 13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
- Website:
- https://evogene.com/
Description
Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-08-31 15:59 |
Reports Second Quarter 2022 Financial Results
|
English | 160.7 KB | ||
| 2022-08-31 15:59 |
Reports Second Quarter 2022 Financial Results
|
English | 35.9 KB | ||
| 2022-08-25 17:19 |
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
|
English | 67.8 KB | ||
| 2022-08-25 17:19 |
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
|
English | 36.0 KB | ||
| 2022-08-17 01:29 |
ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant …
|
English | 263.4 KB | ||
| 2022-08-17 01:29 |
ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant …
|
English | 36.1 KB | ||
| 2022-08-03 15:59 |
Immediate Report of Meeting to be held on SEPTEMBER 8, 2022, Proxy statement
|
English | 1.4 MB | ||
| 2022-08-03 15:59 |
Immediate Report of Meeting to be held on SEPTEMBER 8, 2022, Proxy statement
|
English | 357.9 KB | ||
| 2022-08-03 15:59 |
Immediate Report of Meeting to be held on SEPTEMBER 8, 2022, Proxy statement
|
English | 125.1 KB | ||
| 2022-08-02 15:59 |
Evogene will release its financial results for the second quarter of 2022 on We…
|
English | 152.7 KB | ||
| 2022-08-02 15:59 |
Evogene will release its financial results for the second quarter of 2022 on We…
|
English | 36.1 KB | ||
| 2022-07-28 16:29 |
Biomica Appoints Professor Gal Markel to Company’s Scientific Advisory Board
|
English | 122.2 KB | ||
| 2022-07-28 16:29 |
Biomica Appoints Professor Gal Markel to Company’s Scientific Advisory Board
|
English | 36.0 KB | ||
| 2022-07-26 15:59 |
Biomica Announces First Patient Dosed in its Phase I Study of its Microbiome-Ba…
|
English | 257.2 KB | ||
| 2022-07-26 15:59 |
Biomica Announces First Patient Dosed in its Phase I Study of its Microbiome-Ba…
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evogene Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evogene Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
